HB 1148
(110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, specifies that any person licensed by the board of pharmacy and holding a valid wholesaler license will be considered to be licensed as a drug distributor until such a time when the board can promulgate rules to implement the third-party logistic provider (3PL) licensing process. - Amends TCA Title 63.
|
Feb 01 2017 |
Effective Date(S) 05/04/2017
May 11 2017
|
SB 429
(110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes the department of health to establish a prescription drug donation repository program. - Amends TCA Title 56; Title 63 and Title 68.
|
Jan 30 2017 |
Comp. Became Pub. Ch. 392
May 23 2017
|
HB 137
(110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes the department of health to establish a prescription drug donation repository program. - Amends TCA Title 56; Title 63 and Title 68.
|
Jan 30 2017 |
Effective Date(S) 05/18/2017; 01/01/2018
May 23 2017
|
SB 2027
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires annual reporting to the department of health of the number of oral prescriptions for schedule II controlled substances filled under the existing emergency situation exception to the general written prescription requirement. - Amends TCA Title 53 and Title 63.
|
Jan 30 2018 |
Assigned To S/C Health Subcommittee
Feb 05 2018
|
HB 2102
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires annual reporting to the department of health of the number of oral prescriptions for schedule II controlled substances filled under the existing emergency situation exception to the general written prescription requirement. - Amends TCA Title 53 and Title 63.
|
Jan 30 2018 |
Assigned To S/C Health Subcommittee
Feb 05 2018
|
SB 2570
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires that a prescriber's written recommendation of a controlled substance be deemed to be a prescription for the substance. - Amends TCA Title 53 and Title 63.
|
Jan 29 2018 |
Taken Off Notice For Cal In S/C Health Subcommittee Of Health Committee
Mar 14 2018
|
HB 1989
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires that a prescriber's written recommendation of a controlled substance be deemed to be a prescription for the substance. - Amends TCA Title 53 and Title 63.
|
Jan 29 2018 |
Taken Off Notice For Cal In S/C Health Subcommittee Of Health Committee
Mar 14 2018
|
SB 2222
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, directs the commissioner of health to study issues related to healthcare access and healthcare status of populations affected by the implementation of the Addiction Treatment Act of 2015, Chapter 396 of the Public Acts of 2015; the commissioner shall report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
|
Jan 18 2018 |
Taken Off Notice For Cal In S/C Health Subcommittee Of Health Committee
Mar 14 2018
|
HB 1610
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, directs the commissioner of health to study issues related to healthcare access and healthcare status of populations affected by the implementation of the Addiction Treatment Act of 2015, Chapter 396 of the Public Acts of 2015; the commissioner shall report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
|
Jan 18 2018 |
Taken Off Notice For Cal In S/C Health Subcommittee Of Health Committee
Mar 14 2018
|
HB 2466
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the comptroller of the treasury to study the process utilized by the state to purchase prescription drugs by looking at the role of pharmacy benefits managers, the role of co-payments in drug costs to the consumer and the state, and the desirability of a bid process approved by the general assembly; requires the comptroller to report to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 4; Title 8; Title 56 and Title 71.
|
Feb 01 2018 |
Taken Off Notice For Cal In S/C State Government Subcommittee Of State Government Committee
Mar 28 2018
|
SB 2415
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the comptroller of the treasury to study the process utilized by the state to purchase prescription drugs by looking at the role of pharmacy benefits managers, the role of co-payments in drug costs to the consumer and the state, and the desirability of a bid process approved by the general assembly; requires the comptroller to report to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 4; Title 8; Title 56 and Title 71.
|
Feb 01 2018 |
Taken Off Notice For Cal In S/C State Government Subcommittee Of State Government Committee
Mar 28 2018
|
HB 2618
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, creates sales tax of ten cents per opioid pill dispensed pursuant to prescription; collected tax to be allocated for drug education, prevention, and treatment, including drug courts. - Amends TCA Title 16, Chapter 22; Title 16, Chapter 6 and Title 67.
|
Feb 01 2018 |
Taken Off Notice For Cal In S/C Finance, Ways & Means Subcommittee Of Finance, Ways & Means Committee
Apr 18 2018
|
SB 2444
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, creates sales tax of ten cents per opioid pill dispensed pursuant to prescription; collected tax to be allocated for drug education, prevention, and treatment, including drug courts. - Amends TCA Title 16, Chapter 22; Title 16, Chapter 6 and Title 67.
|
Feb 01 2018 |
Taken Off Notice For Cal In S/C Finance, Ways & Means Subcommittee Of Finance, Ways & Means Committee
Apr 18 2018
|
HB 2221
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the commissioner of health to study issues related to responses by health insurance entities and healthcare providers to the implementation of the Tennessee Prescription Safety Act of 2016, Chapter 1002 of the Public Acts of 2016; requires the commissioner to report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 53; Title 56; Title 63 and Title 71.
|
Jan 31 2018 |
Placed On Senate Finance, Ways, And Means Committee Calendar For 4/24/2018
Apr 24 2018
|
SB 2565
(110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the commissioner of health to study issues related to responses by health insurance entities and healthcare providers to the implementation of the Tennessee Prescription Safety Act of 2016, Chapter 1002 of the Public Acts of 2016; requires the commissioner to report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 53; Title 56; Title 63 and Title 71.
|
Jan 31 2018 |
Placed On Senate Finance, Ways, And Means Committee Calendar For 4/24/2018
Apr 24 2018
|
HB 2220
(110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.
|
Jan 31 2018 |
Comp. Became Pub. Ch. 893
May 08 2018
|
SB 2361
(110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.
|
Jan 31 2018 |
Effective Date(S) 07/01/2018
May 08 2018
|
SB 202
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or there is a request from the user not to do so. - Amends TCA Title 53 and Title 63.
|
Jan 29 2019 |
Filed For Introduction
Jan 29 2019
|
SB 963
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, enacts the "Prescription Drug Fair Pricing Act." - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Feb 05 2019 |
Assigned To General Subcommittee Of Senate Commerce And Labor Committee
Apr 09 2019
|
HB 887
(111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, enacts the "Prescription Drug Fair Pricing Act." - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
|
Feb 05 2019 |
Assigned To General Subcommittee Of Senate Commerce And Labor Committee
Apr 09 2019
|
